Parenteral nutrition (PN) is commonly used in pediatric institutions in patients who either cannot be fed enterally or are unable to tolerate sufficient enteral calories to provide their nutrition requirements. Many pediatric patients, particularly those with short bowel syndrome or intestinal failure, will eventually require home PN (HPN) therapy. Although discharge to HPN is complex and can be associated with both immediate and long-term complications, it can be successfully achieved through collaboration between healthcare providers within the institution and the home care company and HPN education of the patient and caregivers. This review describes the processes that clinicians and institutions should consider when preparing for HPN discharge and serves as a guide for the effective transition to HPN in pediatric patients.
Standards for specialized nutrition support: home care patients. A.S.P.E.N. Board of Directors and the Standards for Specialized Nutrition Support Task Force. Nutr Clin Pract. 2005;20:579-590.
2.
OpillaMTKirbyDFEdmondMB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31:302-305.
3.
MouwEChessmanKLesherATaggeE. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg. 2008;43:1025-1029.
4.
SandersJPithieAGanlyP. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed in haematology patients. J Antimicrob Chemother. 2008;62:809-815.
5.
CrillCMTillmanEMChungJSHelmsRA. Ethanol lock therapy and the incidence of catheter-related bloodstream infections in pediatric home parenteral nutrition patients. J Pediatr Pharmacol Ther. 2009;14:173.
6.
CoberMPKovacevichDSTeitelbaumDH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2011;35:67-73.
7.
Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. JPEN J Parenter Enteral Nutr. 2002;26(1 suppl):1SA-138SA.
8.
StoutSMCoberMP. Metabolic effects of cyclic parenteral nutrition infusion in adults and children. Nutr Clin Pract. 2010;25:277-281.
9.
KaytonMLGarneyEGIshillNM. Preliminary results of a phase 1 trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections. J Pediatr Surg. 2010;45:1961-1966.
CrnichCJHalfmannJACroneWCMakiDG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravenous access. Infect Control Hosp Epidemiol. 2005;26:708-714.
13.
ChambersSTPeddieBPithieA. Ethanol disinfection of plastic-adherent micro-organisms. J Hosp Infect. 2006;63:193-196.
14.
TracyJWWebsterLTJr. Drugs used in the chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, tyrpanosomiasis, leishmaniasis, and other protozoal infections. In: HardmanJGLimbirdLEGoodmanGilman A, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 10th ed.New York, NY: McGraw Hill; 2001:1108.
15.
IneckBMasonBJLyonsW. Anemias. In: DiPiroJTTalbertRLYeeGC, eds. Pharmacotherapy: A Pathophysiologic Approach. 7th ed.New York, NY: McGraw Hill; 2008:1639-1663.
16.
KillipSBenettJMChambersMD. Iron deficiency anemia. Am Fam Physician. 2007;75:671-678.
17.
ClarkSF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol. 2009;25:122-128.
18.
PhelpsSJHakEBCrillCM. Pediatric Injectable Drugs. 9th ed.Bethesda, MD: American Society of Health-System Pharmacists; 2010.
19.
MeyerMPHaworthCMeyerJHCommerfordA. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr. 1996;129:258-263.
20.
PollakAHaydeMHaynM. Effects of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics. 2001;107:78-85.
21.
SuricoGMuggeoPMuggeoV. Parenteral iron supplementation for the treatment of iron deficiency anemia in children. Ann Hematol. 2002;81:154-157.
22.
MichaudLGuimberDMentionK. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. Clin Nutr. 2002;21:403-407.
23.
LeijnEMonnensLACornelissenEA. Intravenous iron supplementation in children on hemodialysis. J Nephrol. 2004;17:423-426.
24.
PinskVLevyJMoserAYerushalmiBKapelushnikJ. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. Isr Med Assoc J. 2008;10:335-338.
25.
HallKCrarySE. Intravenous iron sucrose for children with iron deficiency and/or gastrointestinal hemorrhage [abstract]. Blood. 2009;114:2006.
26.
BailieGRClarkJALaneCELanePL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20:1443-1449.
27.
WysowskiDKSwartzLBBorders-HemphillBVGouldingMRDormitzerC. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010;85:650-654.
28.
AndrisDKrzywdaEA, eds. The A.S.P.E.N. Nutrition Support Patient Education Manual. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2008.
29.
The Oley Foundation. http://www.oley.org. Updated January7, 2011. Accessed January 19, 2011.
30.
SzeszyckiECruseWStrupM. Evaluation and monitoring of pediatric patients receiving specialized nutrition support. In: CorkinsMR, ed. The A.S.P.E.N. Pediatric Nutrition Support Core Curriculum. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2010:460-476.
